Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: Ixabepilone|DRUG: Capecitabine|DRUG: Motesanib
Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Collaborators: Susan G. Komen Breast Cancer Foundation|Amgen